science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0704396 on February 23, 2005

Published online before print February 23, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0704396v1
77/5/719    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rana, S. N.
Right arrow Articles by Choudhry, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rana, S. N.
Right arrow Articles by Choudhry, M. A.
(Journal of Leukocyte Biology. 2005;77:719-728.)
© 2005 by Society for Leukocyte Biology

Inhibition of IL-18 reduces myeloperoxidase activity and prevents edema in intestine following alcohol and burn injury

Shadab N. Rana, Xiaoling Li, Irshad H. Chaudry, Kirby I. Bland and Mashkoor A. Choudhry1

Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham

1 Correspondence: Center for Surgical Research, University of Alabama at Birmingham, Volker Hall G 094, 1670 University Boulevard, Birmingham, AL 35294. E-mail: mashkoor.choudhry{at}ccc.uab.edu


arrow
ABSTRACT
 
Previous studies have shown that alcohol (EtOH) ingestion before burn injury impaired intestinal barrier and immune function. This study determined whether EtOH and burn injury up-regulate interleukin (IL)-18 and whether IL-18 up-regulation following EtOH and burn injury is a cause for neutrophil recruitment and increased intestinal edema. Rats (250 g) were gavaged with EtOH to achieve a blood EtOH level in the range of 100 mg/dL prior to burn or sham injury (25% total body surface area). A group of rats was treated with Ac-YVAD-CHO (5 mg/kg), an inhibitor of caspase-1 (an enzyme that converts pro-IL-18, an inactive form of IL-18, to mature IL-18), at the time of injury. One day after injury, rats were killed. IL-18 production was determined in circulation and in the supernatants harvested from spleen, mesenteric lymph nodes, and Peyer’s patch cell cultures as well as in intestinal tissue homogenates. Neutrophil accumulation in intestine was determined by measuring myeloperoxidase (MPO) activity. We found a significant increase in IL-18 levels in the lymphoid cell supernatants and intestinal tissue homogenates obtained from EtOH and burn-injured rats compared with the rats receiving burn or sham injury. This was accompanied by an increase in intestinal MPO and edema. No demonstrable change in intestinal morphology was observed in any group. Treatment of rats with caspase-1 inhibitor significantly attenuated the increase in IL-18 levels and intestinal MPO activity in EtOH and burn-injured rats. Inhibition of IL-18 also prevented an increase in intestinal tissue water content. As MPO is considered an index of neutrophil infiltration, results presented in this manuscript collectively suggest that IL-18 up-regulation is likely to contribute to the increased neutrophil infiltration and edema in intestinal tissue observed following EtOH and burn injury.

Key Words: thermal injury • alcohol intoxication • cytokine • intestinal permeability • caspase-1 inhibitor • tissue injury


arrow
INTRODUCTION
 
Nearly 1 million burn injuries occur every year with 700,000 annual emergency department visits and 45,000 hospitalizations per year [1 ]. Previous studies have shown that the outcome of burn and trauma victims depends on multiple factors such as age, substance abuse, and sexual dimorphism [2 3 4 5 6 7 8 9 10 11 12 ]. Among these, alcohol (EtOH) intoxication at the time of injury is being recognized as the major factor that exacerbates post-injury pathogenesis [2 , 5 6 7 8 9 10 11 12 13 14 15 ]. Nearly half of the burn patients are found positive for blood EtOH at the time of hospital admission [2 , 5 , 7 , 10 11 12 13 14 ]. The intoxicated patients require frequent intubations and experience delayed wound-healing and unnecessary, longer hospital stays. These patients are more likely to die than the patients who sustained injuries in the absence of EtOH intoxication [5 , 7 , 10 11 12 13 14 ]. Several studies have shown that burn and trauma, regardless of the prior EtOH ingestion, result in a cascade of inflammatory responses characterized by overwhelming production of tumor necrosis factor {alpha}, interleukin (IL)-1, IL-10, prostaglandin E2, and transforming growth factor-ß [4 , 5 , 14 , 16 17 18 ]. Although burn or trauma-mediated, initial release of cytokines or inflammatory mediators is the normal host response to injury, if it remains unchecked, it can lead to multiple organ dysfunction (MODS) and multiple organ failure (MOF). Thus, MODS/MOF becomes the primary cause of death in patients who survive initial injury.

Previous studies have shown that a combined insult of EtOH and burn injury exacerbates the suppression of immune response, resulting in decreased host resistance and enhanced susceptibility to infection [5 6 7 8 9 10 11 12 13 14 15 , 19 , 20 ]. Recent studies from our laboratory and reported by others suggest that acute EtOH ingestion prior to burn injury results in a several-fold increase in bacterial accumulation in the mesenteric lymph nodes (MLN) compared with the animals receiving burn or EtOH alone [8 , 20 ]. Furthermore, we found that increased bacterial accumulation in MLN was accompanied by an increase in intestinal permeability and a decrease in intestinal lymphoid T cell proliferation, IL-2, and interferon-{gamma} (IFN-{gamma}) production [8 ]. Previous studies have implicated intestinal barrier failure and the subsequent translocation of bacteria and/or endotoxin in the development of systemic infection and MOF [16 , 21 22 23 24 ]. In addition to bacteria, the intestine is also being increasingly recognized as the organ that initiates many of the inflammatory responses [5 , 16 , 21 22 23 24 25 26 27 28 29 30 31 ]. These studies have shown that mesenteric lymph from rats subjected to hemorrhagic shock can cause neutrophil activation, endothelial cell permeability, and expression of adhesion molecules on endothelial cells [21 , 26 ].

A multitude of factors, such as neutrophil infiltration and the production of cytokines (e.g., IL-6 and IL-10) and chemokines [e.g., IL-8, cytokine-induced neutrophil chemoattractant (CINC)], have been proposed to contribute to loss of mucosal integrity in burn, hemorrhagic shock, and sepsis [5 , 16 , 21 , 26 , 31 ]. In addition, recent studies have implicated IL-18 in tissue damage in patients and in experimental models of colitis and arthritis as well as in experimental models of sepsis [32 33 34 35 36 37 38 39 40 41 42 43 44 ]. IL-18 was discovered initially to be a factor that enhances IFN-{gamma} production [33 34 35 36 ]; however, recent studies have suggested that IL-18 alone does not induce IFN-{gamma} but rather potentiates an IL-12-mediated increase in IFN-{gamma} (reviewed in ref. [36 ]). Consistent with these findings, our preliminary studies suggested that the decrease in MLN T cell IFN-{gamma} following a combined insult of EtOH intoxication and burn injury is likely a result of a decrease in IL-12 and is independent of IL-18 up-regulation [37 ]. In addition, recent studies suggested that IL-18 plays a role in neutrophil activation and superoxide production [39 40 41 42 43 44 ], although a definitive mechanism by which IL-18 activates neutrophils remains to be established. Previous studies have shown that IL-18 induces production of chemokines including CINC, IL-8, and macrophage-inflammatory protein-1{alpha} [39 , 42 ]. These chemokines in turn can influence neutrophil activation as well as their recruitment. Furthermore, neutrophils are shown to express IL-18 receptors (IL-18Rs) [36 , 39 , 42 43 44 ], and it is likely that an up-regulation of IL-18 following EtOH and burn injury may cause increased neutrophil infiltration in the intestinal tissue. As neutrophil infiltration has been considered a cause for tissue injury [21 , 26 , 29 , 30 , 39 , 43 44 45 46 ], in this study, we determined if an up-regulation of IL-18 is responsible for neutrophil infiltration in the intestine following EtOH and burn injury.


arrow
MATERIALS AND METHODS
 
Animals and reagents
Male Sprague-Dawley rats (225–250 g) were obtained from Charles River Laboratories (Wilmington, MA). Lipopolysaccharide (LPS) derived from Escherichia coli O55:B5 was obtained from Difco (Kansas City, MO). Recombinant IL-18 was purchased from Biosource International (Camarillo, CA). Caspase-1 inhibitor (Ac-YVAD-CHO) was obtained from Axxora LLC (San Diego, CA).

Rat model of acute EtOH and burn injury
As described previously [8 ], rats were divided randomly into four experimental groups: saline + sham; EtOH + sham; saline + burn; and EtOH + burn. In EtOH-treated groups, rats were gavaged with 5 ml 20% EtOH in saline. This resulted in a blood EtOH equivalent to 90–100 mg/dl nearly 4 h after gavage. Earlier, we showed that gavaging rats with 5 ml 20% EtOH results in blood EtOH levels in the range of 170–180 mg/dl within 30 min of EtOH administration. Furthermore, we found that gavaging with 5 ml 40% EtOH resulted in higher circulatory EtOH levels in a range of 380–400 mg/dl within 30 min of EtOH administration [8 ]. These differences in blood EtOH levels, however, were maintained only in the first 4 h, and at the end of 4 h, these levels were 90–100 mg/dl in rats gavaged with 5 ml 20% EtOH and 240–250 mg/dl in those receiving 5 ml 40% EtOH. Regardless of the initial EtOH dose, nearly 70–80% of the circulating EtOH was metabolized within the first 8 h and 100%, 24 h after administration [8 ]. Thus, we used 5 ml 20% EtOH in subsequent studies, as it gave a blood EtOH in the range of 90–100 mg/dl, which is more or less equivalent to legal limits and thus is comparable with those found in a clinical setting [5 6 7 8 9 10 11 12 13 14 15 ]. In saline groups, animals were gavaged with 5 ml saline. Four hours after gavage, all animals were anesthetized with pentobarbital sodium (65 mg/kg). Hairs were shaved from their dorsal body surface. For burn procedure, rats were transferred into a template, which was fabricated to expose 25% of the total body surface area (TBSA). Animals were then immersed in boiling water (95–97°C) for 10 s. Sham-injured animals were subjected to identical anesthesia and other treatments, except that they were immersed in luke-warm water. The animals were dried immediately and given intraperitoneal (i.p.) fluid resuscitation with ~10 ml physiological saline. Animals were allowed to recover from anesthesia and were returned to their cages. Animals were allowed food and water ad libitum. This procedure resulted in a third-degree, full scald burn injury, which results in total loss of nerve endings, and thus, animal do not feel pain. After injury, we did not administer any pain killer, as such treatment of animals will interfere with the outcome of our experiments. The experiments described here were carried out in adherence with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals and are approved by the Institutional Animal Care and Use Committee, University of Alabama at Birmingham.

Measurement of IL-1ß and mature IL-18 levels in culture supernatants prepared from cells of spleen, MLN, and Peyer’s patches (PP)
One day (~24 h) after EtOH and burn injury, animals were anesthetized. The abdominal cavity was exposed, blood was drawn via cardiac puncture, and plasma was separated and stored at –70°C. Spleen, MLN, and PP were collected and were gently crushed to prepare single-cell suspensions in Hanks’ balanced salt solution supplemented with 10 mM HEPES and 50 µg gentamicin/ml. Mixed splenocytes and cells from MLN and PP were suspended in RPMI 1640, supplemented with L-glutamine (2 mM), 2-mercaptoethanol (50 µM), HEPES (10 mM), gentamicin (50 µg/ml), and 10% fetal calf serum, at a density of 5 x 106 cells/ml. The cell suspensions (100 µL) were added to the wells of a 96-well plate [8 ]. Cells were cultured in the absence or presence of 1 or 10 µg/ml LPS. Supernatants were harvested 24 and 48 h later. IL-1ß and mature IL-18 levels were measured in the supernatants using an enzyme-linked immunosorbent assay (ELISA) kit (Biosource International).

Preparation of intestinal homogenates
Immediately after anesthetizing the rats, intestine was exposed. Leaving approximately the first 15-cm-long proximal segment of intestine, a 3-cm-long piece of intestine was removed, cleaned, and snap-frozen. Equal weights (100 mg wet weight) of intestine from various groups were suspended in 1 ml buffer (0.5% hexadecyltrimethylammonium bromide in 50 mM phosphate buffer, pH 6.0) and sonicated at 30 cycles, twice, for 30 s on ice [47 ]. Homogenates were cleared by centrifuging at 12,000 rpm at 4°C, and the supernatants were stored at –70°C. Protein levels in the homogenates were determined using the BioRad (Hercules, CA) assay kit.

Measurement of IL-1ß and mature IL-18 in intestinal tissue
Using ELISA kits (Biosource International), IL-1ß and mature IL-18 levels in intestinal homogenates were determined.

Measurement of myeloperoxidase (MPO) levels
MPO activity in the intestinal homogenates was measured using the procedure described previously [47 ]. Briefly, samples were incubated with a substrate o-dianisidine hydrochloride. This reaction was carried out in a 96-well plate by adding 290 µl 50 mM phosphate buffer, 3 µl substrate solution (containing 20 mg/ml o-dianisidine hydrochloride), and 3 µl H2O2 (20 mM). Sample (10 µl) was added to each well to start the reaction. Standard MPO (Sigma Chemical Co., St. Louis, MO) was used in parallel to determine MPO activity in the sample. The reaction was stopped by adding 3 µL sodium azide (30%). Plates were read at 460 nm. MPO activity was determined by using the curve obtained from the standard MPO.

Measurement of water content
In a separate cohort, intestinal segments were removed, weighed, and dried for 24 h at 80°C [45 ]. Water content (%) of intestinal tissue was calculated as (wet wt–dry wt)/wet wt x 100.

Histological analysis of intestine
As described previously [8 ], three 1-cm-long pieces of small intestine were fixed in 10% formalin in phosphate-buffered saline for 24 h and were sent to the Histology Laboratory at the University of Alabama at Birmingham for further processing. Briefly, the sections were embedded in paraffin. These were then cut (4–5 µm) and mounted on glass slides. Intestine sections were stained with hematoxylin-eosin, observed under the microscope (Nikon Eclipse TS100) at a magnification x200 for changes in intestinal morphology, and photographed using a camera (SPOT, RTcolor, Diagnostic Instrument, Inc, Iowa City, Iowa) attached with the microscope.

Statistical analysis
Results are presented as means ± SE and were analyzed using an ANOVA statistical program (Statistical Package for Social Sciences Software program, Version 2.0, Sigma Stat). A P < 0.05 between two groups was considered as statistically significant.


arrow
RESULTS
 
Plasma levels of IL-18
As illustrated in Figure 1A , the sham group showed IL-18 levels ~20 pg/ml. Compared with the sham group, there was no difference in IL-18 levels in rats receiving EtOH alone. Similarly, no change in serum IL-18 levels was observed in rats subjected to burn injury in the absence of prior EtOH intoxication. The EtOH-plus-burn group also did not exhibit any noticeable increase as compared with sham, as we found the values to be ~25 pg/ml after 24 h of EtOH plus burn injury. Hence, no significant differences in IL-18 levels were noted in any groups.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Circulatory levels (A) and the production of IL-18 by splenocytes (B), MLN (C), and PP (D) following EtOH and burn injury. Animals were killed 24 h after EtOH and burn injury. Blood was drawn via cardiac puncture, and plasma was separated. Mixed cells prepared from spleen, MLN, and PP (5x105 cells/well) were cultured in the presence of LPS (10 µg/ml) for 24 h at 37°C. IL-18 in plasma and in the culture supernatants was determined using ELISA. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham-injured rats regardless of EtOH ingestion and burn-injured rats gavaged with saline; @, P < 0.05, compared with sham-injured rats gavaged with saline.

IL-18 production by splenic and intestinal lymphoid cells
Cells from spleen and intestinal lymphoid organs (MLN and PP) were cultured for 24–48 h in the absence and presence of two different doses of LPS, 1 µg/ml and 10 µg/ml. We did not find any detectable IL-18 in the supernatants harvested from unstimulated as well as in the supernatants harvested from cells cultured in the presence of LPS at 1 µg/ml. Furthermore, no significant differences in IL-18 levels were noted whether the cells were cultured for 24 h or for 48 h. So, based on these observations, we selected 10 µg/ml LPS dose and 24 h as an optimum incubation period for further experiments. Although 10 µg/ml is a relatively high dose of LPS, LPS used in our study was derived from E. coli O55:B5, and a similar dose of LPS of E. coli O55:B5 origin has been used in many previous studies [48 , 49 ]. It is likely that LPS derived from different strains of E. coli behaves differently. As shown in Figure 1 , no significant differences in IL-18 levels were observed in the supernatants harvested from spleen (B), MLN (C), and PP (D) of sham animals, regardless of their EtOH intoxication. Furthermore, the production of IL-18 by MLN and spleen cells was not found to be different in burn-injured rats gavaged with saline compared with sham rats. In contrast, the production of IL-18 by PP was significantly higher in burn-injured rats gavaged with saline compared with sham rats gavaged with saline. However, IL-18 levels in PP of the burn-alone group were not significantly different from IL-18 levels in the PP supernatants obtained from sham rats gavaged with EtOH. A significant (P<0.05) increase in IL-18 levels was noted in spleen, MLN, and PP cells isolated from rats receiving combined insult of EtOH intoxication and burn injury compared with rats receiving burn injury alone or sham-injured rats, regardless of their EtOH intoxication.

IL-18 levels in small intestinal tissue
As shown in Figure 2 , a tendency of an increase in IL-18 levels was observed in homogenates prepared from the small intestine of sham-injured rats gavaged with EtOH compared with sham-injured rats gavaged with saline; however, this increase was not significantly different (P>0.05). A significant (P<0.05) increase in intestinal IL-18 levels was noted in animals in burn-injured rats gavaged with saline compared with sham-injured rats gavaged with saline. The increase in IL-18 levels in intestinal homogenates in burn-injured rats gavaged with saline was not found to be significantly different from IL-18 levels in the intestinal homogenates prepared from sham rats gavaged with EtOH. A further increase (P<0.05) in IL-18 levels was observed in the intestine of EtOH and burn-injured rats compared with sham-injured rats, regardless of their EtOH intoxication. Although IL-18 levels in intestinal tissue following a combined insult of EtOH intoxication and burn injury were higher than those observed in rats receiving burn injury alone in the absence of EtOH, this increase was not found to be significantly different.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2. Intestinal tissue levels of IL-18 following EtOH and burn injury. Animals were killed 24 h after EtOH and burn injury. Equal weights (100 mg) of intestine from various groups were sonicated. Homogenates were cleared by centrifugation, and IL-18 levels in the clear supernatants were determined using ELISA. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham-injured rats regardless of EtOH ingestion; #, P > 0.05, compared with burn-injured rats gavaged with saline; @, P < 0.05, compared with sham-injured rats gavaged with saline.

Small intestinal MPO activity
As shown in Figure 3 , there was no difference in MPO activity in the intestine of sham animals regardless of their EtOH intoxication. A slight increase in MPO activity was noted in intestine following burn injury alone; however, this increase was not found to be significantly different from that observed in sham-injured rats. Intestinal tissue from EtOH and the burn group showed a significantly higher MPO activity (P<0.05) compared with burn-injured rats gavaged with saline or the sham group, regardless of their EtOH ingestion.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 3. MPO activity in intestinal tissue 24 h after EtOH and burn injury. Animals were killed 24 h after EtOH and burn injury. Equal weights (100 mg) of intestine from various groups were suspended in 1 ml buffer containing 0.5% hexadecyltrimethylammonium bromide in 50 mM phosphate buffer (pH 6.0) and sonicated. Homogenates were cleared by centrifugation, and MPO activity in the supernatants was determined as described in Materials and Methods. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham-injured rats regardless of EtOH ingestion and burn-injured rats gavaged with saline.

Histological analysis of intestine
The representative photomicrographs of intestine are presented in Figure 4A from sham gavaged with saline, Figure 4B from sham gavaged with EtOH, Figure 4C from burn gavaged with saline, and Figure 4D from burn gavaged with EtOH. Similar results were obtained from four or more animals in each group. Together, these results, as presented in Figure 4 , suggest no demonstrable damage to the villi or submucosa of the intestine of animals following EtOH and burn injury compared with sham animals.



View larger version (149K):
[in this window]
[in a new window]
 
Figure 4. Representative photomicrographs of small intestine of sham gavaged with saline (A), sham gavaged with EtOH (B), burn gavaged with saline (C), and burn gavaged with EtOH (D). Animals were killed 24 h after EtOH and burn injury. Small intestine was removed and processed as described in Materials and Methods. Intestine sections were stained with hematoxylin-eosin, examined at an original magnification x200, and photographed.

Treatment of rats with caspase-1 inhibitor
Rats were injected i.p. with caspase-1 inhibitor (Ac-YVAD-CHO) at a dose of 5 mg/kg immediately after burn or sham injury. This dose has been used in the previous studies [40 ]. Twenty-four hours after injury, rats were killed, and following, measurements were performed. In evaluating the effects of caspase-1 treatment, we have not included the sham-plus-EtOH group, as data in Figures 1 2 3 did not show any significant differences in IL-18 and MPO activity in sham-injured rats gavaged with saline or EtOH. Thus, subsequent studies were performed using sham-injured rats gavaged with saline.

Effect of caspase-1 inhibitor treatment on IL-18 production by splenic and intestinal lymphoid cells
There was no significant difference in circulatory levels of IL-18 in caspase-1 inhibitor-treated or -untreated rats following EtOH and burn injury (data not shown). As shown in the Figure 5 , administration of casapse-1 inhibitor did not affect splenic (Fig. 5A) MLN (Fig. 5B) , and PP (Fig. 5C) IL-18 production in sham animals; however, similar treatment of rats significantly attenuated the increase in IL-18 in splenic and intestinal lymphoid organs (MLN and PP) after EtOH and burn injury.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 5. Effect of caspase-1 inhibitor on IL-18 production by splenocytes (A), MLN (B), and PP (C) following EtOH and burn injury. Immediately after sham or burn injury, rats were divided randomly into two groups. One group of sham, burn, and EtOH-plus-burn rats was injected i.p. with caspase-1 inhibitor (Ac-YVAD-CHO) at a dose of 5 mg/kg. The other group received a similar amount of vehicle [dimethyl sulfoxide (DMSO)]. Twenty-four hours after injury, rats were killed. Mixed cells prepared from spleen, MLN, and PP (5x105 cells/well) were cultured in the presence of LPS (10 µg/ml) for 24 h at 37°C. IL-18 in the culture supernatants was determined using ELISA. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham- and burn-injured rats gavaged with saline; @, P < 0.05, compared with sham-injured rats gavaged with saline; #, P > 0.05, compared with sham-injured rats.

In vitro treatment of cells with caspase-1 inhibitor
Using a 96-well plate, mixed cells from spleen, MLN, and PP (5x105 cells/well) were first incubated for 30 min at 37°C in the absence and presence of two different doses of caspase-1 inhibitor (25 µM and 50 µM). LPS was then added to each well, and plates were incubated for 24 h at 37°C. Supernatants were harvested for IL-18 levels. The in vitro experiments were performed using cells from sham rats gavaged with saline and burn-injured rats gavaged with EtOH, only because IL-18 was not significantly affected by EtOH intoxication or burn injury alone. Results as shown in Figure 6 suggest that in vitro treatment of cells with caspase-1 inhibitor dose-dependently prevented an IL-18 increase in supernatants harvested from spleen, MLN, and PP cells derived from EtOH and burn-injured rats.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 6. In vitro treatment of spleen, MLN, and PP cells with caspase-1 inhibitor prevented IL-18 production following EtOH and burn injury. Twenty-four hours after injury, rats were killed. Mixed cells prepared from spleen, MLN, and PP (5x105 cells/well) were cultured first, in the presence of vehicle (DMSO) or caspase-1 inhibitor (Ac-YVAD-CHO) at doses 50 µM and 25 µM for 30 min at 37°C. At the end of 30 min, LPS was added to each well, and plates were incubated for 24 h at 37°C. Supernatants were harvested for IL-18 measurement. Data are means ± SE from four animals in each group. *, P < 0.05, compared with sham- and burn-injured rats gavaged with the EtOH group treated with caspase-1 inhibitor.

Effect of caspase-1 inhibitor treatment on intestinal tissue IL-18 levels
Intestinal tissue levels of IL-18 following caspase-1 inhibitor treatment are shown in Figure 7 . Similar to lymphoid organs, there was no effect of caspase-1 inhibitor treatment on intestinal tissue IL-18 level in sham-injured rats. The treatment of rats with caspase-1 inhibitor significantly prevented the increase in intestinal IL-18 levels observed following burn injury with or without prior EtOH intoxication.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 7. Effect of caspase-1 inhibitor on intestinal tissue levels of IL-18 following EtOH and burn injury. Immediately after sham or burn injury, rats were divided randomly into two groups. One group of sham, burn, and EtOH-plus-burn rats was injected i.p. with caspase-1 inhibitor (Ac-YVAD-CHO) at a dose of 5 mg/kg. The other group received a similar amount of vehicle (DMSO). Animals were killed 24 h after EtOH and burn injury. Equal weights (100 mg) of intestine from various groups were sonicated, and IL-18 levels in the homogenates were determined using ELISA. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham-injured rats; @, P < 0.05, compared with sham-injured rats; #, P > 0.05, compared with sham-injured rats.

Effect of caspase-1 inhibitor treatment on IL-1 production by splenic, intestinal lymphoid cells and intestinal tissue
As caspase-1 is also involved in IL-1 synthesis [32 , 33 , 36 , 40 ], we determined if treatment of rats with caspase-1 inhibitor Ac-YVAD-CHO influences IL-1 levels. We did not observe any detectable levels of IL-1 in plasma harvested 24 h after injury as well as in the supernatants harvested from intestinal lymphoid cells obtained from sham or injured rats. IL-1 levels in the supernatants harvested from sham splenocytes was 25 ± 3 pg/ml, which was not significantly different from splenocytes harvested from burn-injured animals gavaged with saline (33±8 pg/ml) or EtOH (23±3.3 pg/ml). Treatment of rats with caspase-1 inhibitor did not influence splenocyte IL-1 levels. IL-1 levels in intestinal tissue homogenates, are presented in Figure 8 . There was no difference in IL-1 levels in intestinal tissue homogenates prepared from sham-injured rats gavaged with saline (351±18 pg/100 mg wet tissue) or EtOH (339±34 g/100 mg wet tissue). However, a significant decrease in IL-1 levels was observed in intestinal tissue homogenates prepared from EtOH and burn-injured rats compared with rats receiving sham injury. Although there was a decrease in IL-1 levels in intestinal tissue homogenates prepared from burn-injured rats gavaged with saline compared with sham-injured rats, this was not found to be significantly different. Treatment of rats with caspase-1 inhibitor significantly reduced IL-1 levels in sham intestinal tissue homogenates, and a similar treatment of burn-injured rats gavaged with saline or EtOH did not influence further intestinal levels.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 8. Effect of caspase-1 inhibitor on intestinal tissue levels of IL-1 following EtOH and burn injury. Immediately after sham or burn injury, rats were divided randomly into two groups. One group of sham, burn, and EtOH-plus-burn rats was injected i.p. with caspase-1 inhibitor (Ac-YVAD-CHO) at a dose of 5 mg/kg. The other group received a similar amount of vehicle (DMSO). Animals were killed 24 h after EtOH and burn injury. Equal weights (100 mg) of intestine from various groups were sonicated, and IL-1 levels in the homogenates were determined using ELISA. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham-injured rats.

Effect of caspase-1 inhibitor treatment on intestinal MPO activity
As shown in the Figure 9 , administration of caspase-1 inhibitor did not influence MPO activity in sham-injured rats as well as in rats receiving burn injury alone in the absence of EtOH. However, similar administration of casapse-1 inhibitor significantly attenuated the increase in MPO activity in intestinal tissue obtained from rats receiving a combined insult of EtOH intoxication and burn injury.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 9. Effect of caspase-1 inhibitor on intestinal tissue MPO activity following EtOH and burn injury. Immediately after sham or burn injury, rats were divided randomly into two groups. One group of sham, burn, and EtOH-plus-burn rats was injected i.p. with caspase-1 inhibitor (Ac-YVAD-CHO) at a dose of 5 mg/kg. The other group received a similar amount of vehicle (DMSO). Animals were killed 24 h after EtOH and burn injury. Equal weights (100 mg) of intestine from various groups were sonicated, and MPO activity in the supernatants was determined as described in Materials and Methods. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham- and burn-injured rats gavaged with saline; #, P > 0.05, compared with sham-injured rats.

Effect of caspase-1 inhibitor treatment on intestinal tissue edema
Intestinal tissue water content in untreated and caspase-1 inhibitor-treated animals is shown in Figure 10 . There was no significant difference in the water content in intestinal tissue obtained from burn-injured rats gavaged with saline as compared with sham-injured rats, regardless of EtOH intoxication. However, a substantial increase (P<0.05) in water content was observed in intestine of EtOH and burn-injured rats compared with burn-injured rats gavaged with saline and sham rats, regardless of their EtOH intoxication. As EtOH and burn-injured rats is the only group that exhibited a significant increase in their intestinal tissue water contents, we decided to treat this group with caspase-1 inhibitor. The results, as shown in Figure 9 , clearly suggest that treatment of rats with caspase-1 inhibitor at the time of injury significantly prevented the increase in water contents.



View larger version (11K):
[in this window]
[in a new window]
 
Figure 10. Effect of caspase-1 inhibitor on intestinal tissue edema following EtOH and burn injury. Immediately after injury, EtOH and burn-injured rats were divided randomly into two groups. One group of EtOH-plus-burn rats was injected i.p. with caspase-1 inhibitor (Ac-YVAD-CHO) at a dose of 5 mg/kg. The other group received a similar amount of vehicle (DMSO). Animals were killed 24 h after EtOH and burn injury. Intestinal segments were removed, weighed, and dried for 24 h at 80°C. Water content (%) of intestinal tissue was calculated as (wet wt–dry wt)/wet wt x 100. Data are means ± SE from at least six animals in each group. *, P < 0.05, compared with sham-injured rats, regardless of EtOH ingestion, burn-injured rats gavaged with saline and EtOH-plus-burn-injured rats treated with caspase-1 inhibitor. #, P > 0.05, compared with sham-injured rats.


arrow
DISCUSSION
 
The findings included in this manuscript suggest that a combined insult of EtOH intoxication and burn injury up-regulates IL-18 production in spleen and intestinal lymphoid organs. No significant difference in circulatory levels of IL-18 was observed in rats receiving a combined insult of EtOH intoxication and burn injury compared with rats receiving EtOH intoxication or burn injury alone. It is likely that IL-18 is degraded by 24 h after injury, or we may have missed the peak elevation in circulation. This could be a reason why it is important to measure inflammatory mediators locally at the tissue levels, as circulatory levels are not always good predictors. Our studies suggested that the increase in IL-18 levels in lymphoid cells and intestinal tissue is accompanied by an increase in intestinal MPO activity (an index for neutrophil accumulation). The treatment of rats with capsase-1 inhibitor at the time of injury prevented the increase in IL-18 production, intestinal MPO activity, as well as the increase in intestinal edema. These findings support the hypothesis that a combined insult of EtOH intoxication and burn injury leads to IL-18 up-regulation, which in turn, may play a role in neutrophil recruitment to the intestinal tissue and in the development of intestinal edema following EtOH and burn injury.

IL-18 is mainly produced by activated macrophages, Kupffer cells, dendritic cells, Langerhans cells, and B cells [32 , 36 ]. In addition IL-18 is shown to be produced in the lamina propria as well as by intestinal epithelial cells [33 34 35 36 ]. IL-18 is synthesized as a nonfunctional precursor, pro-IL-18. Studies have shown that protease activity mediated by IL-1-converting enzyme, also referred to as caspase-1, is needed for conversion of pro-IL-18 to the mature, functional protein [33 34 35 36 ]. The activity of IL-18 can also be regulated after release by IL-18-binding protein (IL-18bp), which is normally present in serum. IL-18bp can bind IL-18 and block bioavailability and subsequent function [38 ]. In our study, we treated rats with caspase-1 inhibitor Ac-YVAD-CHO and then examined the effects of IL-18 on post-EtOH and burn injury-mediated neutrophil accumulation and edema in small intestine. Ac-YVAD-CHO has been used in previous studies and is found to be specific for its action on caspase-1 [32 , 40 ]. As caspase-1 also plays a role in IL-1 production, we determined IL-1 levels in our experiments to rule out the role of IL-1 [33 34 35 36 ]. As discussed in Results, we did not observe detectable/significant IL-1 levels in plasma or in the immune cell culture supernatants in any experimental group. However, in intestinal tissue homogenates, there was a significant decrease in IL-1 following EtOH and burn injury compared with sham-injured rats. This is in contrast to IL-18, which is up-regulated following EtOH and burn injury. The treatment of rats with caspase-1 inhibitor (Ac-YVAD-CHO) at 5 mg/kg did not influence further intestinal IL-1 levels in EtOH and burn-injured rats, and a similar treatment clearly blocked IL-18 synthesis. The mechanism of such differential roles of caspase-1 in regulation of IL-1 and IL-18 remains to be established. Previous studies have shown that IL-18 is constitutively expressed, and IL-1 is not [32 ]. It is likely that caspase-1 does not regulate immature forms of IL-1 and IL-18 but rather participates only in the maturation process of available biologically immature IL-1 or IL-18. Furthermore, it is possible that IL-1 and IL-18 production follows different kinetics following EtOH and burn injury. Although we plan to explore all these possibilities in future investigations, the results presented in this manuscript collectively suggest a relationship between IL-18 up-regulation and neutrophil recruitment as well as in the development of intestinal edema following EtOH and burn injury.

IL-18, like IL-12, was discovered initially to be a factor that enhances IFN-{gamma} production [33 34 35 36 ]. It is not surprising, therefore, that it appears essential to host defenses against a variety of infections. IL-18 is particularly effective during the clearance of intracellular bacteria, fungi, and protozoa, requiring the induction of host-derived IFN-{gamma}. In a recent study, Ami et al. [50 ] have shown that IL-18 administration following burn injury restored IFN-{gamma} production and prevented mortality from subsequent sepsis induced by cecal ligation and puncture (CLP). In contrast, our preliminary findings suggest that the decrease in IFN-{gamma} following EtOH and burn injury is likely a result of a decrease in IL-12 and is independent of IL-18. Although the difference between the two studies remains to be established, such variations could result from a different experimental model used in the two studies. Ami et al. [50 ] induced 20% TBSA burn injury in mice by a heated brass blade before CLP, and in our studies, rats were gavaged with EtOH 4 h before receiving 25% burn injury by immersing them into the ~95°C hot water. Recent studies suggested that like many other proinflammatory cytokines, IL-18 possesses broad, immunomodulatory properties. Emmanuilidis et al. [51 ] recently have shown that IL-12 was reduced significantly in sepsis patients compared with control, surgical patients without sepsis. In contrast to IL-12, IL-18 serum levels were significantly higher in sepsis patients than in controls. Furthermore, they observed that IL-18 levels were increased significantly in patients with lethal sepsis compared with sepsis survivors at all time-points studied. From these findings, Emmanuilidis et al. [51 ] have concluded that IL-12 may contribute to protective immune reactions against a septic challenge, whereas IL-18 may preferentially promote organ injury and lethal shock. Additional findings suggest that IL-18 induces a wide array of inflammatory responses, such as the expression of adhesion molecules, intercellular adhesion molecule-1, in different cell types, activation of nuclear factor-{kappa}B, Fas ligand expression, and induction of chemokines [33 34 35 36 37 38 39 40 41 42 43 44 ]. IL-18 is often expressed in inflammatory lesions and is found to be elevated in the blood of patients with a variety of diseases including Crohn’s disease, Sjogren syndrome, graft-versus-host disease, and rheumatoid arthritis [41 ]. These studies suggested that inappropriate IL-18 production contributes to the pathogenesis of these diseases and may influence the clinical outcome of these patients. Although many of these studies suggested IL-18-induced IFN-{gamma} as the cause for tissue damage [33 34 35 36 , 41 ], others have supported the role of neutrophil recruited by IL-18 [39 , 40 , 42 43 44 ]. As in our studies we observed a decrease in IFN-{gamma} [7 ], it is unlikely that IFN-{gamma} is involved in intestinal tissue damage following EtOH and burn injury; instead, IL-18-mediated, increased neutrophil recruitment to intestine is likely to play a role in increased intestinal edema and permeability. The mechanism by which IL-18 up-regulation following EtOH and burn injury mediates neutrophil recruitment to intestine remains to be established.

Previous studies have shown that neutrophils constitutively express IL-18R ({alpha} and ß), and thus, IL-18 can activate multiple neutrophil functions including superoxide production [36 , 44 ]. Jordan et al. [39 ] have shown that intratracheal administration of IL-18 caused significant increases in lung vascular permeability and resulted in increased infiltration of neutrophils. Conversely, intratracheal instillation of anti-IL-18 in inflamed lung greatly reduced the recruitment of these cells and prevented an increase in vascular permeability. Similarly, intratracheal administration of IL-18bp also resulted in suppressed lung vascular permeability and decreased bronchoalveolar lavage content of neutrophils, cytokines, and chemokines. Consistent with these studies, Sir et al. [45 ] have shown that neutrophil antiserum prevents the increase in intestinal permeability and edema following burn injury. As IL-18Rs are present on neutrophil, IL-18 can activate and recruit neutrophil directly. Alternatively, IL-18 can induce the production of chemokines such as CINC [39 , 42 , 43 ], which in turn, can influence neutrophil activation and their recruitment to intestinal tissue. Although in the present study, we have not determined the mechanism by which neutrophil causes tissue injury following EtOH and burn injury, previous studies have shown that insult such as EtOH intoxication or burn results in neutrophil activation and production of free oxygen radical (O2) [25 , 26 , 29 , 30 , 46 ]. Although such intracellular O2 production in neutrophils is essential for pathogen killing, an excessive production of O2 and its release to the extracellular environment can cause tissue damage. Such neutrophil-mediated tissue injury is demonstrated in pathological conditions of acute and chronic EtOH intoxication, rheumatoid arthritis, acute respiratory distress syndrome, and tissue ischemia [25 , 26 , 29 , 30 , 39 40 41 42 43 44 45 46 ]. It is interesting to note that in many of the injury conditions, the chemotactic factors for neutrophil recruitment to tissue/organ originate from the cells at sites of inflammation, and thus, inflamed tissue/organs themselves become the source for such chemotactic response. Consistent with this hypothesis, we observed a significant increase in IL-18 levels in intestinal homogenates prepared from EtOH and burn-injured rats compared with those from sham-injured rats. Thus, an increase in IL-18 level, locally in intestinal tissue, directly, or via inducing neutrophil chemotactic factor (e.g., CINC), may play a role in neutrophil recruitment to intestine following EtOH and burn injury.

In summary, results presented here suggest a role of IL-18 in increased neutrophil (determined by MPO activity) recruitment to the intestine following EtOH and burn injury. Whether neutrophil recruitment is a direct effect of IL-18 or is a result of an up-regulation of neutrophil chemotactic factors such as CINC remains to be established. Regardless of the mechanism, once neutrophils are recruited, they can potentiate a microvascular blockade, leading to tissue hypoperfusion, or penetrate through extracellular spaces into a submucosal region to cause an increase in intestinal permeability and edema (reviewed in ref. [30 ]). In the present study, we have not determined intestinal permeability; rather, we examined the development of intestinal edema, which is another important index of tissue injury. Consistent with increased intestinal permeability as reported previously [8 ], we observed a significant increase in intestinal tissue water content in rats receiving a combined insult of EtOH intoxication and burn injury compared with the rats receiving EtOH intoxication or injury alone. The finding of a decreased intestinal MPO activity and edema along with IL-18 in EtOH and burn-injured rats treated with caspase-1 (IL-18) inhibitor suggests that IL-18 is likely to play a role in neutrophil accumulation and increased edema in intestine following EtOH and burn injury.


arrow
ACKNOWLEDGEMENTS
 
This study was supported from NIH through AA12901. Financial support from the Department of Surgery, University of Alabama at Birmingham, is acknowledged.

Received July 12, 2004; revised January 14, 2005; accepted January 25, 2005.


arrow
REFERENCES
 
    1
  1. Burn incidence and treatment in the US: 2000 fact sheet American Burn Association http://www.ameriburn.org/pub/BurnIncidenceFactSheet.htm.
  2. 2
  3. Jones, J. D., Barber, B., Engrav, L., Heimbach, D. (1991) Alcohol use and burn injury J. Burn Care Rehabil. 12,148-152[Medline]
  4. 3
  5. Saffle, J. R. (1998) Predicting outcomes of burns N. Engl. J. Med. 338,362-366[Abstract/Free Full Text]
  6. 4
  7. Schwacha, M. G., Chaudry, I. H. (2002) The cellular basis of post-burn immunosuppression: macrophages and mediators Int. J. Mol. Med. 10,239-243[Medline]
  8. 5
  9. Choudhry, M. A., Gamelli, R. L., Chaudry, I. H. (2004) Alcohol abuse: a major contributing factor to post burn/trauma immune complications Vincent, J-L. eds. Yearbook of Intensive Care and Emergency Medicine ,15-26 Springer-Yale New York, NY.
  10. 6
  11. Faunce, D. E., Gregory, M. S., Kovacs, E. J. (1997) Effects of acute ethanol exposure on cellular immune responses in a murine model of thermal injury J. Leukoc. Biol. 62,733-740[Abstract]
  12. 7
  13. Grobmyer, S. R., Maniscalco, S. P., Purdue, G. F., Hunt, J. L. (1996) Alcohol, drug intoxication, or both at the time of burn injury as a predictor of complications and mortality in hospitalized patients with burns J. Burn Care Rehabil. 17,532-539[CrossRef][Medline]
  14. 8
  15. Choudhry, M. A., Fazal, N., Goto, M., Gamelli, R. L., Sayeed, M. M. (2002) Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury Am. J. Physiol. Gastrointest. Liver Physiol. 282,G937-G947[Abstract/Free Full Text]
  16. 9
  17. Kawakami, M., Switzer, B. R., Herzog, S. R., Meyer, A. A. (1991) Immune suppression after acute ethanol ingestion and thermal injury J. Surg. Res. 51,210-215[CrossRef][Medline]
  18. 10
  19. Kelley, D., Lynch, J. B. (1992) Burns in alcohol and drug users result in longer treatment times with more complications J. Burn Care Rehabil. 13,218-220[CrossRef][Medline]
  20. 11
  21. Maier, R. V. (2001) Ethanol abuse and the trauma patient Surg. Infect. (Larchmt.) 2,133-141
  22. 12
  23. McGill, V., Kowal-Vern, A., Fisher, S. G., Kahn, S., Gamelli, R. L. (1995) The impact of substance use on mortality and morbidity from thermal injury J. Trauma 38,931-934[Medline]
  24. 13
  25. McGwin, G., Chapman, V., Rousculp, M., Robison, J., Fine, P. (2000) The epidemiology of fire-related deaths in Alabama, 1992–1997 J. Burn Care Rehabil. 21,75-83[Medline]
  26. 14
  27. Messingham, K. A., Faunce, D. E., Kovacs, E. J. (2002) Alcohol, injury, and cellular immunity Alcohol 28,137-149[CrossRef][Medline]
  28. 15
  29. Szabo, G., Mandrekar, P., Verma, B., Isaac, A., Catalano, D. (1994) Acute ethanol consumption synergizes with trauma to increase monocyte tumor necrosis factor {alpha} production late postinjury J. Clin. Immunol. 14,340-352[CrossRef][Medline]
  30. 16
  31. Deitch, E. A. (2001) Role of the gut lymphatic system in multiple organ failure Curr. Opin. Crit. Care 7,92-98[CrossRef][Medline]
  32. 17
  33. Faist, E., Schinkel, C., Zimmer, S. (1996) Update on the mechanisms of immune suppression of injury and immune modulation World J. Surg. 20,454-459[CrossRef][Medline]
  34. 18
  35. Choudhry, M. A., Fazal, N., Namak, S. Y., Haque, F., Ravindranath, T., Sayeed, M. M. (2001) PGE2 suppresses intestinal T cell function in thermal injury: a cause of enhanced bacterial translocation Shock 16,183-188[Medline]
  36. 19
  37. Choudhry, M. A., Messingham, K. A., Namak, S., Colantoni, A., Fontanilla, C. V., Duffner, L. A., Sayeed, M. M., Kovacs, E. J. (2000) Ethanol exacerbates T cell dysfunction after thermal injury Alcohol 21,239-243[CrossRef][Medline]
  38. 20
  39. Napolitano, L. M., Koruda, M. J., Zimmerman, K., McCowan, K., Chang, J., Meyer, A. A. (1995) Chronic ethanol intake and burn injury: evidence for synergistic alteration in gut and immune integrity J. Trauma 38,198-207[Medline]
  40. 21
  41. Deitch, E. A., Shi, H. P., Lu, Q., Feketeova, E., Skurnick, J., Xu, D. Z. (2004) Mesenteric lymph from burned rats induces endothelial cell injury and activates neutrophils Crit. Care Med. 32,533-538[CrossRef][Medline]
  42. 22
  43. Enomoto, N., Ikejima, K., Bradford, B. U., Rivera, C. A., Kono, H., Goto, M., Yamashina, S., Schemmer, P., Kitamura, T., Oide, H., Takei, Y., Hirose, M., Shimizu, H., Miyazaki, A., Brenner, D. A., Sato, N., Thurman, R. G. (2000) Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury J. Gastroenterol. Hepatol. 15(Suppl.),D20-D25
  44. 23
  45. Hassoun, H. T., Kone, B. C., Mercer, D. W., Moody, F. G., Weisbrodt, N. W., Moore, F. A. (2001) Post-injury multiple organ failure: the role of the gut Shock 15,1-10
  46. 24
  47. Herndon, D. N., Zeigler, S. T. (1993) Bacterial translocation after thermal injury Crit. Care Med. 21,S50-S54[Medline]
  48. 25
  49. Keshavarzian, A., Holmes, E. W., Patel, M., Iber, F., Fields, J. Z., Pethkar, S. (1999) Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage Am. J. Gastroenterol. 94,200-207[CrossRef][Medline]
  50. 26
  51. Moore, E. E. (1998) Mesenteric lymph: the critical bridge between dysfunctional gut and multiple organ failure Shock 10,415-416[Medline]
  52. 27
  53. Tabata, T., Tani, T., Endo, Y., Hanasawa, K. (2002) Bacterial translocation and peptidoglycan translocation by acute ethanol administration J. Gastroenterol. 37,726-731[CrossRef][Medline]
  54. 28
  55. Alnadjim, Z., Kayali, Z., Haddad, W., Holmes, E. W., Keshavarzian, A., Mittal, N., Ivancic, D., Koehler, R., Goldsmith, D., Waltenbaugh, C., Barrett, T. A. (2002) Differential effects of T-cell activation on gastric and small bowel permeability in alcohol-consuming mice Alcohol. Clin. Exp. Res. 26,1436-1443[Medline]
  56. 29
  57. Fazal, N., Shamim, M., Zagorski, J., Choudhry, M. A., Ravindranath, T., Sayeed, M. M. (2000) CINC blockade prevents neutrophil Ca(2+) signaling upregulation and gut bacterial translocation in thermal injury Biochim. Biophys. Acta 1535,50-59[Medline]
  58. 30
  59. Sayeed, M. M. (2000) Exuberant Ca(2+) signaling in neutrophils: a cause for concern News Physiol. Sci. 15,130-136[Abstract/Free Full Text]
  60. 31
  61. Wang, W., Smail, N., Wang, P., Chaudry, I. H. (1998) Increased gut permeability after hemorrhagic shock is associated with upregulation of local and systemic IL-6 J. Surg. Res. 79,39-46[CrossRef][Medline]
  62. 32
  63. Siegmund, B. (2002) Interleukin-1ß converting enzyme (caspase-1) in intestinal inflammation Biochem. Pharmacol. 64,1-8[CrossRef][Medline]
  64. 33
  65. Gracie, J. A., Robertson, S. E., McInnes, I. B. (2003) Interleukin-18 J. Leukoc. Biol. 73,213-224[Abstract/Free Full Text]
  66. 34
  67. Pages, F., Lazar, V., Berger, A., Danel, C., Lebel-Binay, S., Zinzindohoue, F., Desreumaux, P., Cellier, C., Thiounn, N., Bellet, D., Cugnenc, P. H., Fridman, W. H. (2001) Analysis of interleukin-18, interleukin-1 converting enzyme (ICE) and interleukin-18-related cytokines in Crohn’s disease lesions Eur. Cytokine Netw. 12,97-104[Medline]
  68. 35
  69. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K. (1995) Cloning of a new cytokine that induces IFN-{gamma} production by T cells Nature 378,88-91[CrossRef][Medline]
  70. 36
  71. Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H. (2001) Interleukin-18 regulates both Th1 and Th2 responses Annu. Rev. Immunol. 19,423-474[CrossRef][Medline]
  72. 37
  73. Choudhry, M. A., Gamelli, R. L., Chaudry, I. H., Sayeed, M. M. (2003) Differential regulation of IL-12 and IL-18 in mesenteric lymph nodes of alcohol and burn-injured rats Shock 19,6(abstract).
  74. 38
  75. Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., Rubinstein, M. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response Immunity 10,127-136[CrossRef][Medline]
  76. 39
  77. Jordan, J. A., Guo, R. F., Yun, E. C., Sarma, V., Warner, R. L., Crouch, L. D., Senaldi, G., Ulich, T. R., Ward, P. A. (2001) Role of IL-18 in acute lung inflammation J. Immunol. 167,7060-7068[Abstract/Free Full Text]
  78. 40
  79. Joshi, V. D., Kalvakolanu, D. V., Hebel, J. R., Hasday, J. D., Cross, A. S. (2002) Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia Infect. Immun. 70,6896-6903[Abstract/Free Full Text]
  80. 41
  81. Kashiwamura, S., Ueda, H., Okamura, H. (2002) Roles of interleukin-18 in tissue destruction and compensatory reactions J. Immunother. 25(Suppl.),S4-S11
  82. 42
  83. Leung, B. P., Culshaw, S., Gracie, J. A., Hunter, D., Canetti, C. A., Campbell, C., Cunha, F., Liew, F. Y., McInnes, I. B. (2001) A role for IL-18 in neutrophil activation J. Immunol. 167,2879-2886[Abstract/Free Full Text]
  84. 43
  85. Netea, M. G., Fratuzzi, G., Kullberg, B. J., Stuyt, R. J., Pulido, E. J., McIntyre, R. C., Jr, Joosten, L. A., Van der Meer, J. W., Dinarello, C. A. (2000) Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against Escherichia coli and Salmonella typhimurium endotoxemia J. Immunol. 164,2644-2649[Abstract/Free Full Text]
  86. 44
  87. Wyman, T. H., Dinarello, C. A., Banerjee, A., Gamboni-Robertson, F., Hiester, A. A., England, K. M., Kelher, M., Silliman, C. C. (2002) Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation J. Leukoc. Biol. 72,401-409[Abstract/Free Full Text]
  88. 45
  89. Sir, O., Fazal, N., Choudhry, M. A., Goris, R. J., Gamelli, R. L., Sayeed, M. M. (2000) Role of neutrophils in burn-induced microvascular injury in the intestine Shock 14,113-117[Medline]
  90. 46
  91. Fazal, N., Al-Ghoul, W. M., Schmidt, M. J., Choudhry, M. A., Sayeed, M. M. (2002) Lyn- and ERK-mediated vs. Ca2+-mediated neutrophil O responses with thermal injury Am. J. Physiol. Cell Physiol. 283,C1469-C1479[Abstract/Free Full Text]
  92. 47
  93. Salter, J. W., Krieglstein, C. F., Issekutz, A. C., Granger, D. N. (2001) Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation Am. J. Physiol. Gastrointest. Liver Physiol. 281,G1432-G1439[Abstract/Free Full Text]
  94. 48
  95. Knoferl, M. W., Jarrar, D., Angele, M. K., Ayala, A., Schwacha, M. G., Bland, K. I., Chaudry, I. H. (2001) 17 ß-Estradiol normalizes immune responses in ovariectomized females after trauma-hemorrhage Am. J. Physiol. Cell Physiol. 281,C1131-C1138[Abstract/Free Full Text]
  96. 49
  97. Chung, C. S., Song, G. Y., Lomas, J., Simms, H. H., Chaudry, I. H., Ayala, A. (2003) Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity J. Leukoc. Biol. 74,344-351[Abstract/Free Full Text]
  98. 50
  99. Ami, K., Kinoshita, M., Yamauchi, A., Nishikage, T., Habu, Y., Shinomiya, N., Iwai, T., Hiraide, H., Seki, S. (2002) IFN-{gamma} production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18 J. Immunol. 169,4437-4442[Abstract/Free Full Text]
  100. 51
  101. Emmanuilidis, K., Weighardt, H., Matevossian, E., Heidecke, C. D., Ulm, K., Bartels, H., Siewert, J. R., Holzmann, B. (2002) Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome Shock 18,301-305[CrossRef][Medline]



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
F.-C. Liu, Y.-J. Day, C.-H. Liao, J.-T. Liou, C.-C. Mao, and H.-P. Yu
Hemeoxygenase-1 Upregulation Is Critical for Sirtinol-Mediated Attenuation of Lung Injury After Trauma-Hemorrhage in a Rodent Model
Anesth. Analg., June 1, 2009; 108(6): 1855 - 1861.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. D. Bird and E. J. Kovacs
Organ-specific inflammation following acute ethanol and burn injury
J. Leukoc. Biol., September 1, 2008; 84(3): 607 - 613.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Li, M. G. Schwacha, I. H. Chaudry, and M. A. Choudhry
Heme Oxygenase-1 Protects against Neutrophil-Mediated Intestinal Damage by Down-Regulation of Neutrophil p47phox and p67phox Activity and O2- Production in a Two-Hit Model of Alcohol Intoxication and Burn Injury
J. Immunol., May 15, 2008; 180(10): 6933 - 6940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Li, E. J. Kovacs, M. G. Schwacha, I. H. Chaudry, and M. A. Choudhry
Acute alcohol intoxication increases interleukin-18-mediated neutrophil infiltration and lung inflammation following burn injury in rats
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1193 - L1201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H.-P. Yu, S. Yang, Y.-C. Hsieh, M. A. Choudhry, K. I. Bland, and I. H. Chaudry
Maintenance of lung myeloperoxidase activity in proestrus females after trauma-hemorrhage: upregulation of heme oxygenase-1
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L400 - L406.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
X. Li, S. N. Rana, M. G. Schwacha, I. H. Chaudry, and M. A. Choudhry
A novel role for IL-18 in corticosterone-mediated intestinal damage in a two-hit rodent model of alcohol intoxication and injury
J. Leukoc. Biol., August 1, 2006; 80(2): 367 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-P. Yu, T. Shimizu, Y.-C. Hsieh, T. Suzuki, M. A. Choudhry, M. G. Schwacha, and I. H. Chaudry
Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage
J. Leukoc. Biol., May 1, 2006; 79(5): 963 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-P. Yu, M. A. Choudhry, T. Shimizu, Y.-C. Hsieh, M. G. Schwacha, S. Yang, and I. H. Chaudry
Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1
J. Leukoc. Biol., February 1, 2006; 79(2): 277 - 284.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0704396v1
77/5/719    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rana, S. N.
Right arrow Articles by Choudhry, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rana, S. N.
Right arrow Articles by Choudhry, M. A.